Lakewood-Amedex, Inc.
Bisphosphocins—novel antimicrobial compounds that disrupt microbial membranes to treat infections
- Sector
- Biotech
- Headquarters
- SARASOTA, FL
- Latest Form D
- $24.1M, Jan 2021
- Total capital
- $30M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $30M
- 3 Form D · last Jan 2021
- 69 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 12
- 28 pending · first 2017
- Rank in peer group#139 of 1462
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$24.1M
- Private capital raisedForm D · SEC · 2nd filing$456K
- Private capital raisedForm D · SEC · 1st filing$5.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1462 peers
Line = medianBiotech · Molecule
- Granted patents#139 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Charles WrightDirectorNamed in SEC Form D filings
- Edward Russell McAllisterExecutive OfficerNamed in SEC Form D filings
- Geoffrey E CoxDirectorNamed in SEC Form D filings
- Leonard James DeRomaDirectorNamed in SEC Form D filings
- Patrick Coleman O'ConnorExecutive OfficerNamed in SEC Form D filings
- Paul Anthony DiTullioExecutive Officer, DirectorNamed in SEC Form D filings
Show all 13 people
- Peter Coleman CeccacciExecutive OfficerNamed in SEC Form D filings
- Peter CorrDirectorNamed in SEC Form D filings
- Richard Ford HammExecutive OfficerNamed in SEC Form D filings
- Stephen M MileyDirectorNamed in SEC Form D filings
- Steven ParkinsonExecutive Officer, DirectorNamed in SEC Form D filings
- Steve ParkinsonExecutive Officer, DirectorNamed in SEC Form D filings
- Teddy Wallace BrownDirectorNamed in SEC Form D filings
What it has protected
USPTO · 12 granted of 40- PendingBisphosphocin Gel Formulations And Uses ThereofUSPTOApplication 18933370
- GrantedBisphosphocin Gel Formulations And Uses ThereofUSPTOUS 12,156,883
- PendingAntimicrobial Compounds, Compositions, And Uses ThereofUSPTOApplication 18793205
Show all 40 patent records
- Bisphosphocin Gel Formulations And Uses ThereofAug 21, 2025 · Application 18933370Pending
- Bisphosphocin Gel Formulations And Uses ThereofDec 3, 2024 · US 12,156,883Granted
- Antimicrobial Compounds, Compositions, And Uses ThereofNov 28, 2024 · Application 18793205Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofOct 31, 2024 · Application 18756504Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofAug 6, 2024 · US 12,054,509Granted
- Antiviral Compounds, Compositions, And Uses ThereofJul 25, 2024 · Application 18540055Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofJul 9, 2024 · US 12,030,908Granted
- Antimicrobial Compounds, Compositions, And Uses ThereofOct 24, 2023 · US 11,795,192Granted
- Bisphosphocin Gel Formulations And Uses ThereofApr 27, 2023 · Application 18083378Pending
- Methods For Preparing BisphosphocinsMar 23, 2023 · Application 17871494Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofJul 5, 2022 · US 11,377,468Granted
- Methods And Compositions For Treating Oral MucositisDec 23, 2021 · Application 17459248Pending
- Methods And Compositions For Treating Oral MucositisSep 21, 2021 · US 11,123,357Granted
- Bisphosphocin Gel Formulations And Uses ThereofAug 24, 2021 · US 11,096,954Granted
- Antimicrobial Compounds, Compositions, And Uses ThereofMay 13, 2021 · Application 16492861Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofApr 20, 2021 · US 10,981,943Granted
- Bisphosphocin Gel Formulations And Uses ThereofNov 19, 2020 · Application 16943939Pending
- Antimicrobial Compounds, Compositions, And Uses ThereofAug 25, 2020 · US 10,752,651Granted
- Antimicrobial Compounds, Compositions, And Uses ThereofJul 14, 2020 · US 10,711,028Granted
- Compositions And Methods For The Treatment Of Influenza InfectionAug 13, 2019 · US 10,378,014Granted
- Antimicrobial Compounds, Compositions, And Uses ThereofSep 13, 2018 · Application 15919138Pending
- Oligonucleotide-containing Pharmacological Compositions And Their UseFeb 14, 2017 · US 9,567,584Granted
- Bisphosphocin Compounds And Their Use As AntimicrobialsApplication 62470039Pending
- Bisphosphocin Compounds And Their Use As AntimicrobialsApplication 62470025Pending
- Substituted Pyrimidinone And Azapyrimidinone Compounds, Compositions, And Uses ThereofApplication 19478698Pending
- Crystalline Forms Of NU-3 And Uses ThereofApplication 19616960Pending
- Substituted Bicyclic Heterocycle Compounds, Compositions, And Uses ThereofApplication 19478661Pending
- Substituted Pyrimidinedione Compounds, Compositions, And Uses ThereofApplication 19478658Pending
- Crystalline Forms Of NU-3 And Uses ThereofApplication PCTUS2025017096Pending
- Substituted Pyrimidinedione Compounds, Compositions, And Uses ThereofApplication PCTUS2024026369Pending
- Substituted Bicyclic Heterocycle Compounds, Compositions, And Uses ThereofApplication PCTUS2024026372Pending
- Substituted Pyrimidinone And Azapyrimidinone Compounds, Compositions, And Uses ThereofApplication PCTUS2024026526Pending
- Crystalline Forms Of NU-3 And Uses ThereofApplication 63556774Pending
- Antiviral Compounds, Compositions, And Uses ThereofApplication PCTUS2023084050Pending
- Substituted Pyrimidinone And Azapyrimidinone Compounds, Compositions, And Uses ThereofApplication 63498460Pending
- Substituted Pyrimidinedione Compounds, Compositions, And Uses ThereofApplication 63498467Pending
- Substituted Bicyclic Heterocycle Compounds, Compositions, And Uses ThereofApplication 63498469Pending
- Antiviral Compounds, Compositions, And Uses ThereofApplication 63432576Pending
- Methods For Preparing BisphosphocinsApplication PCTUS2022038040Pending
- Syntheses Of Bisphosphocins Avoiding The Use Of Tetrazole And Tertiary Butyl PeroxideApplication 63300354Pending
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.